Details for New Drug Application (NDA): 040023
✉ Email this page to a colleague
NDA 040023 describes ADRUCIL, which is a drug marketed by Pharmacia And Upjohn and Teva Parenteral and is included in four NDAs. Additional details are available on the ADRUCIL profile page.
The generic ingredient in ADRUCIL is fluorouracil. There are fifteen drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the fluorouracil profile page.
The generic ingredient in ADRUCIL is fluorouracil. There are fifteen drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the fluorouracil profile page.
Summary for 040023
| Tradename: | ADRUCIL |
| Applicant: | Teva Parenteral |
| Ingredient: | fluorouracil |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 040023
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 50MG/ML | ||||
| Approval Date: | Oct 18, 1991 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
